Division of Allergy Pulmonary and Critical Care Medicine Archive — Page 4 of 4

Three smiling adults pose in a laboratory surrounded by shelves of equipment and chemical containers; glass bottles and flasks sit in the foreground.
February 6, 2020

Team tracks integrin’s role in lung function

Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered.

By Bill Snyder
3d rendering white blood cells with red blood cells
October 8, 2019

A new regulator of B cell development

New findings establish a role for the pro-inflammatory molecule IL-33 in the early development of antibody-producing B cells.

By Leigh MacMillan
Jonathan D. Casey, MD, seated in front of bookshelves, with on-screen text identifying him as a Pulmonary and Critical Care Fellow at Vanderbilt University Medical Center.
February 18, 2019

VUMC study finds helping patients breathe during intubation prevents life-threatening complications

Thousands of Americans die each year during a dangerous two-minute procedure to insert a breathing tube. Now a Vanderbilt University Medical Center (VUMC) study in the New England Journal of Medicine (NEJM) is showing that using bag-mask ventilation, squeezing air from a bag into the mouth for 60 seconds to help patients’ breathing, improves outcomes and could potentially save lives.

By Craig Boerner
March 27, 2018

Alzheimer’s proteins in ICU survivors

The cognitive impairment that affects patients who survive a stay in the ICU does not appear to have a similar mechanism to Alzheimer’s disease, Vanderbilt researchers have discovered.

By Meredith Jackson
February 12, 2018

Protecting transplanted lungs

Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered.

By Leigh MacMillan
Stylized front-view anatomical illustration of the human torso showing the lungs and branching airways highlighted in yellow and orange within a translucent purple chest.
February 1, 2018

Study tracks therapy to slow idiopathic pulmonary fibrosis

Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course.

By Nancy Humphrey